TME heads into its August 11 earnings report carrying a striking divergence between a recovering share price and a deeply sceptical analyst community.
The stock has climbed over 10% in the past month to $9.53, with a modest 0.85% gain on the week. Short sellers are not pressing their case into the print. Short interest has fallen nearly 10% over the past month to around 30 million shares. The borrow market is loose — availability runs near 789%, meaning there are roughly eight shares available to lend for every one currently borrowed. Cost to borrow is negligible at 0.56%. The ORTEX short score has edged lower over the past two weeks, from 45.2 to 43.2, reflecting a gradual reduction in bearish pressure. Options positioning is essentially neutral: the put/call ratio of 0.91 sits just below its 20-day average, with a z-score barely negative. Nothing in the positioning data suggests investors are bracing for a sharp move in either direction.
The analyst picture is where the tension lies. The mean price target sits at $101, which appears stale or reflects a pre-ADR-restructuring baseline — TME trades near $9.53, an order of magnitude below that figure, so the consensus target should be treated with caution. What is credible and recent: JP Morgan cut its target to $10 and moved to Neutral in May, effectively calling the stock fairly valued at current levels. Mizuho trimmed to $18 while holding Outperform. Earlier in the year, UBS downgraded to Neutral, JPMorgan moved from Overweight to Neutral, and Macquarie cut to Neutral — a broad sweep of downgrades that set a cautious baseline. Barclays and Morgan Stanley have maintained positive ratings but continued trimming targets. The direction of travel for the Street has been consistently downward on conviction, even as some houses retain constructive ratings.
Bulls have two genuine anchors. The dividend score ranks in the 98th percentile, suggesting meaningful yield support relative to peers. The company ranks in the 92nd percentile on EPS surprise, meaning it has a track record of beating estimates. Forward earnings momentum over 12 months ranks at the 72nd percentile — a sign that analysts expect growth even if they have been cutting near-term targets. The EV/EBITDA multiple of 6.3x is modest for an entertainment streaming platform with dominant China market share. Bears point to the opposite: momentum factor scores are weak across all time horizons, the stock is down sharply year-to-date despite the recent bounce, and the regulatory and geopolitical backdrop for Chinese ADRs remains a structural overhang that no earnings beat easily removes.
On the ownership side, Tencent Holdings controls 52.7% of shares, and Spotify holds a further 9%. With over 60% of shares locked in strategic hands, the free float is limited — which helps explain why the lending pool is technically abundant but the stock can still move sharply on modest volume. Schroder added over 4.5 million shares through Q2, and Invesco reported a position build of over 15 million shares as of July 31 — two active managers adding into the weakness.
The print is therefore less a test of whether TME can beat a lowered bar and more a question of whether management guidance is strong enough to close the gap between the stock's $9.53 reality and the scattered double-digit price targets that the remaining bulls are still defending.
See the live data behind this article on ORTEX.
Open TME on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
